AI assistant
Sending…
AUGA group — Director's Dealing 2020
Apr 22, 2020
2259_rns_2020-04-22_7e8a2ad7-8421-4923-85c3-2ee252940f75.pdf
Director's Dealing
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
Anesthesia and Intensive Care Unit
ARMANDAS ŠIMULIS
2020-04-21 15:37:04 GMT+3
Paekhts Paradas
Notification of transaction by person discharging managerial responsibilities
| 1. | Details of the person discharging managerial responsibilities | ||
|---|---|---|---|
| a) | Name | Armandas Šimulis | |
| 2. | Reason for the notification | ||
| a) | Position/status | Acting Head of R&D Department | |
| b) | Initial notification/ Amendment | Initial notification | |
| 3. | Details of the issuer | ||
| a) | Name | AUGA group, AB | |
| b) | LEI | 48510000P2S3LHJPX414 | |
| 4. | Details of the transaction | ||
| a) | Description of the financial instrument, type of instrument Identification code | Execution of option agreement to obtain issuer’s shares in the future N/A | |
| b) | Nature of the transaction | Execution of the share option agreement to obtain issuer’s shares in the future under the Programme for granting issuer’s shares to employees, management and supervisory board members of the issuer and its subsidiaries approved by the general shareholders’ meeting on 2018-04-30 | |
| c) | Price and volume | Price | Volume |
| EUR 0 | 45 000 units | ||
| d) | Aggregated information — Aggregated volume — Price | Employee shall after 3 years be entitled to elect to get from the issuer up to 45 000 units of the issuer’s shares Shares shall be granted to the employee for free (i.e. for EUR 0) | |
| e) | Date of the transaction | 2020-04-21 | |
| f) | Place of the transaction | Outside a trading venue |
Note: This option agreement was executed under the Programme for granting issuer's shares to employees, management and supervisory board members of the issuer and its subsidiaries approved by the general shareholders' meeting on 2018-04-30
Armandas Šimulis, Acting Head of R&D Department
/name, surname, position, signature/
More from AUGA group
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 30
Capital/Financing Update
2026
Apr 13
Capital/Financing Update
2026
Apr 13
Report Publication Announcement
2026
Apr 8
Report Publication Announcement
2026
Apr 8